Supply Issues Baxter Healthcare Administration Sets Multiple Products (ICN 1868)

• The supplier Baxter Healthcare has informed us that the supply issue with its Administration Sets is still ongoing.
• The product listing has been updated to reflect the latest Demand Management statuses.
• The supply issue is now anticipated to be resolved by 30 April 2023.

• The supplier Baxter Healthcare has informed us that the supply issue with its Administration Sets is still ongoing.
• The supply issue is now anticipated to be resolved by 31 March 2023.

• The supplier Baxter Healthcare has informed us that the supply issue with its Administration Sets is still ongoing.
• Three product codes are now available to order through our online catalogue.
• Four product codes are currently subject to Protect Demand Management:
  • FSC092, FSB1117, FSB689 and FSB1244.
• Two product codes are suspended and unavailable to order:
  • FSB998 and FSB1941.
• See our Downloads ▼ section for a full list of product codes subject to Protect Demand Management.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives.
• The supply issue is anticipated to be resolved by 17 March 2023.

• The supplier Baxter Healthcare has informed us that a number of products which are listed as indirect alternatives for this supply issue are now subject to supply constraints.
• The following product codes are currently suspended and unavailable to order.
  • FSB1884, FSB1880, FKA011, FSB1247 and FKA344.
• Two product codes are currently subject to Protect Demand Management:
  • FSB2659, and FSB1185.
• The product codes are available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity aka “threshold” to ensure fair supply of available stock across the NHS.
• FSB2571 is now subject to Control Demand Management. If you have an urgent clinical need for any of the suspended codes, you need to complete and submit the Control Suspended Consumables Product Submission Webform. See our Useful Links section to access this web form.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential indirect alternatives.

• The supplier Baxter Healthcare has informed us of supply issues with an additional product within its range of its Administration Sets. There are now seven codes affected.
• FSB1244 (MPC MMC9609L) Administration sets for pump and gravity Colleague pumps Pump/gravity blood administration set flexible double chamber with ball valve 200um filter rotary luer with hydrophobic cap 225cm date/time label is now suspended and is subject to Control Demand Management. This will need to be ordered via the Control Suspended Consumables Product Submission Webform.
• The supplier has advised us that at this time there are no alternatives available for customers using NPC FSB1244 (MPC MMC9609L) with the Evo IQ and Colleague LVP infusion pumps.
• The supplier has advised that in order to protect supply please only use NPC FSB1244 (MPC MMC9609L) blood pump administration sets in the Baxter Evo IQ and Colleague infusion pumps when it is absolutely necessary to pump blood. Please use a gravity blood administration sets where possible and when only gravity infusion is required.
• The expected resolution for the supply of all affected codes is as follows:
  • FSB998, FSB1244, FSB1117 and FSB85012 – mid January 2023
  • FSC092 and FSB689 – February 2023
  • FSB1941 – March 2023.
• See our Downloads section to access the product listing for further information on the affected product codes and potential indirect alternatives, Baxter Customer Letter, Baxter Joint guidance on supply disruption, and Baxter Clinical Product Matrix.
• Any updates to Demand Management or Suspension status of the affected products and their indirect alternatives will continue to be updated on a weekly basis.

Change:

• The supplier Baxter Healthcare has informed us of supply issues with a range of its Administration Sets.
• There are six product codes affected.
• This is due to an issue with the labelling of these products which has led to a supply disruption.
• There is a potential for Clinical and / or Patient Safety impacts as a result of this issue.

Impact:

• The affected product codes are currently suspended.
• One of the suspended products, FSC092, is subject to Control Demand Management.
• The potential indirect alternatives may be subject to Protect Demand Management.
• The product listing has been updated with the demand management status of each product:
  • Control – These products are unavailable to order as they are subject to Control Demand Management. If you have an urgent clinical need for any of the suspended codes and have not been able to source them through the Mutual Aid process, you need to complete and submit the Control Suspended Consumables Product Submission Webform. See our Useful Links section to access this web form on our Demand Management page.
  • Protect – These products are being threshold managed and are subject to Protect Demand Management. The product codes remain available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity “threshold” to ensure fair supply of available stock across the NHS. See our Downloads section for a full list of product codes subject to Protect Demand Management.
  • Sustain– These products are available to order, however excessive single requests for demand may be subject to Demand Management.
• Any updates to Demand Management or Suspension status of the affected products and their indirect alternatives will be updated on a weekly basis
• See our Downloads section to access the product listing for further information on the affected product codes and potential alternatives.
• Please note this supply disruption also affects a number of irrigation sets, please refer to ICN 1869 for further information.
• The supply issue is anticipated to be ongoing until early 2023.

Next Steps:

• Customers are advised to log into our website to review the suggested potential indirect alternative products, taking into account their clinical suitability.
• The supplier has provided some additional information around alternatives, please refer to the attached letter.
• We have included a copy of the Information for Clinical Choice (ICC) matrix for IV administration sets where customers can find further details of suitable alternatives. Please note, the listed alternatives in the ICC and product listing may be subject to intermittent supply and a number of these are currently suspended.
• Customers may wish to consider single chamber gravity blood sets as an alternative; however this will be based on local clinical assessment of suitability.
• A number of the affected products are pump dedicated administration sets, for further guidance on alternatives please contact the supplier’s product manager lee_thompson@baxter.com.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.